Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Hepatitis C and SLC28A3[original query] |
---|
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenetics and genomics 2011 May 21 (5): 289-96. Doehring Alexandra, Hofmann Wolf Peter, Schlecker Christina, Zeuzem Stefan, Sarrazin Christoph, Berg Thomas, Müller Tobias, Herrmann Eva, Geisslinger Gerd, Lötsch Jö |
Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy. Pharmacogenomics 2011 Dec 12 (12): 12. Lötsch J, Hofmann WP, Schlecker C, Zeuzem S, Geisslinger G, Ultsch A, Doehring A |
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology 2013 Apr 58 (4): 669-75. Rau Monika, Stickel Felix, Russmann Stefan, Manser Christine N, Becker Philip P, Weisskopf Michael, Schmitt Johannes, Dill Michael T, Dufour Jean-François, Moradpour Darius, Semela David, Müllhaupt Beat, Geier Andreas, |
Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. Therapeutic drug monitoring 2012 Dec 34 (6): 6. D?avolio A, Ciancio A, Siccardi M, Smedile A, Simiele M, Cusato J, Baietto L, Marucco DA, Cariti G, Calcagno A, Gonzalez de Requena D, Sciandra M, Troshina G, Caviglia GP, Bonora S, Rizzetto M, Di Perri G |
Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: